JP2005504804A5 - - Google Patents

Download PDF

Info

Publication number
JP2005504804A5
JP2005504804A5 JP2003530306A JP2003530306A JP2005504804A5 JP 2005504804 A5 JP2005504804 A5 JP 2005504804A5 JP 2003530306 A JP2003530306 A JP 2003530306A JP 2003530306 A JP2003530306 A JP 2003530306A JP 2005504804 A5 JP2005504804 A5 JP 2005504804A5
Authority
JP
Japan
Prior art keywords
weight
composition
dexamethasone
pharmaceutical composition
ciprofloxacin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003530306A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005504804A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/029373 external-priority patent/WO2003026671A1/en
Publication of JP2005504804A publication Critical patent/JP2005504804A/ja
Publication of JP2005504804A5 publication Critical patent/JP2005504804A5/ja
Pending legal-status Critical Current

Links

JP2003530306A 2001-09-21 2002-09-13 中耳感染を処置する方法 Pending JP2005504804A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32395101P 2001-09-21 2001-09-21
PCT/US2002/029373 WO2003026671A1 (en) 2001-09-21 2002-09-13 Method of treating middle ear infections

Publications (2)

Publication Number Publication Date
JP2005504804A JP2005504804A (ja) 2005-02-17
JP2005504804A5 true JP2005504804A5 (OSRAM) 2006-01-05

Family

ID=23261416

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003530306A Pending JP2005504804A (ja) 2001-09-21 2002-09-13 中耳感染を処置する方法

Country Status (19)

Country Link
US (8) US20030139382A1 (OSRAM)
EP (1) EP1429780B1 (OSRAM)
JP (1) JP2005504804A (OSRAM)
KR (1) KR20040035760A (OSRAM)
CN (1) CN1231218C (OSRAM)
AT (1) ATE313328T1 (OSRAM)
AU (1) AU2002333671B2 (OSRAM)
BR (1) BR0212898A (OSRAM)
CA (1) CA2459930C (OSRAM)
CY (1) CY1104988T1 (OSRAM)
DE (1) DE60208216T2 (OSRAM)
DK (1) DK1429780T3 (OSRAM)
ES (1) ES2250739T3 (OSRAM)
FR (1) FR13C0012I2 (OSRAM)
MX (1) MXPA04002576A (OSRAM)
PL (1) PL212457B1 (OSRAM)
RU (1) RU2295346C2 (OSRAM)
WO (1) WO2003026671A1 (OSRAM)
ZA (1) ZA200401847B (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0212898A (pt) * 2001-09-21 2004-10-13 Alcon Inc Método de tratamento de infecções do ouvido médio
US7220431B2 (en) * 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
PL1776109T3 (pl) * 2004-08-13 2009-06-30 Schering Plough Ltd Farmaceutyczna formulacja zawierająca antybiotyk, triazol i kortykosteroid
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US20080139545A1 (en) * 2006-05-22 2008-06-12 Won-Taek Choe Formulation to treat ear infection
WO2008085913A1 (en) * 2007-01-04 2008-07-17 Rib-X Pharmaceuticals, Inc. Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections
US8088095B2 (en) * 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
US20090263345A1 (en) * 2008-01-28 2009-10-22 Foresight Biotherapeutics, Inc. Otic compositions for the treatment of infections of the internal and external ear in mammals
WO2009139924A2 (en) 2008-05-14 2009-11-19 Otonomy, Inc. Controlled release corticosteroid compositions and methods for the treatment of otic disorders
US8784790B2 (en) 2008-06-12 2014-07-22 Medtronic Xomed, Inc. Method for treating chronic wounds with an extracellular polymeric substance solvating system
BRPI0916323A2 (pt) * 2008-07-21 2018-05-29 Otonomy Inc composições antimicrobianas de liberação controlada e métodos para o tratamento de distúrbios do ouvido
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US20100016450A1 (en) * 2008-07-21 2010-01-21 Otonomy, Inc. Controlled release delivery devices for the treatment of otic disorders
US20100086576A1 (en) * 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
TW201023912A (en) 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
CN102340993A (zh) * 2009-03-03 2012-02-01 爱尔康研究有限公司 向眼部递送受体酪氨酸激酶抑制性(RTKi)化合物的药物组合物
WO2010101989A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
EP2440165A4 (en) * 2009-06-08 2014-01-22 Otic Pharma Ltd FOAM FORMULATIONS FOR THE EAR
WO2011049958A2 (en) * 2009-10-21 2011-04-28 Otonomy, Inc. Modulation of gel temperature of poloxamer-containing formulations
US10653133B2 (en) 2011-05-10 2020-05-19 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
US9561240B2 (en) * 2012-12-26 2017-02-07 Otic Pharma Ltd. Foamable otic pharmaceutical compositions
WO2015031393A1 (en) 2013-08-27 2015-03-05 Otonomy, Inc. Treatment of pediatric otic disorders
US20150119371A1 (en) * 2013-10-30 2015-04-30 Micro Labs Limited Topical pharmaceutical compositions of antibiotics and steroidal anti inflammatory agents
CN106794144B (zh) 2014-07-03 2020-07-17 奥德纳米有限公司 环丙沙星组合物的灭菌
US9393243B1 (en) * 2015-07-14 2016-07-19 Nilesh Parikh Topical Ciprofloxacin compositions
WO2018053173A1 (en) 2016-09-16 2018-03-22 Otonomy, Inc. Otic gel formulations for treating otitis externa
IT201900005280A1 (it) * 2019-04-05 2020-10-05 Ntc S R L Composizione otologica

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3134718A (en) * 1963-12-12 1964-05-26 Schering Corp Pregna-1,4-dienes and compositions containing same
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US5223493A (en) * 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US4686214A (en) * 1985-10-30 1987-08-11 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
DE3704907A1 (de) * 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
WO1990001933A1 (en) * 1988-08-26 1990-03-08 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
SU1811833A1 (ru) * 1989-06-09 1993-04-30 Vladimir I Ivanov Способ введения лекарственных средств в ухо 2
DE69224071T2 (de) * 1991-09-17 1998-05-07 Alcon Lab Inc Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
ES2065846B1 (es) 1993-04-20 1995-10-01 Cusi Lab Formulacion farmaceutica a base de un agente antiinflamatorio esteroidico o no esteroidico y un antibiotico pertenciente al grupo de los inhibidores de la adn girasa para su utilizacion topica oftalmica.
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
ES2078175B1 (es) 1993-12-31 1996-10-16 Cusi Lab Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.
ES2079320B1 (es) * 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
US5843930A (en) * 1995-06-06 1998-12-01 Bayer Corporation Method of treating otitis with ciprofloxacin-hydrocortisone suspension
ES2173287T3 (es) 1995-06-06 2002-10-16 Bayer Ag Composiciones oticas antibacterianas no irritantes, no sensibilizantes y no ototoxicas.
DE19524691A1 (de) * 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
ES2106680B1 (es) * 1995-08-03 1998-07-01 Vita Invest Sa Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액
AR020660A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
AU6275999A (en) 1998-09-30 2000-04-17 Alcon Laboratories, Inc. Antibiotic compositions for treatment of the eye, ear and nose
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
EP1214056B1 (en) * 1999-09-24 2003-10-29 Alcon Inc. Topical suspension formulations containing ciprofloxacin and dexamethasone
BR0212898A (pt) * 2001-09-21 2004-10-13 Alcon Inc Método de tratamento de infecções do ouvido médio

Similar Documents

Publication Publication Date Title
CA2459930A1 (en) Method of treating middle ear infections
US6599883B1 (en) Nasal delivery of xylitol
ES2207549T3 (es) Formulaciones en suspension topicas que contienen ciprofloxacino y desametasona.
JP4748289B2 (ja) 点眼剤、眼科用組成物及び吸着抑制方法
AU2005311738B2 (en) Topical nepafenac formulations
ES2530719T3 (es) Formulaciones de oxicodona para ser administradas una vez al día
JP2017019846A (ja) 点眼剤
KR20150011807A (ko) 자일리톨계 항-점액성 조성물과 관련 방법 및 조성물
AU2002333671A1 (en) Method of treating middle ear infections
JP2001187728A (ja) 眼科用組成物
JP2001158734A (ja) 眼科用組成物及びソフトコンタクトレンズに対する吸着抑制方法
JP2006528990A5 (OSRAM)
JP2013535472A5 (OSRAM)
JP2009509956A (ja) 非イオン性界面活性剤を使用して中耳内への経膜的薬物送達を促進する、中耳炎の処置および予防のための方法
CA2544139A1 (en) Suspension of loteprednol etabonate and tobramycin for topical ophthalmic use
JP2011021002A (ja) 眼科用組成物
JP2003520813A5 (OSRAM)
US20070212343A1 (en) Compositions for treatment of ear infections
JP3175742B1 (ja) コンタクトレンズ用眼科用組成物
CN101087607B (zh) 眼用组合物及使用其的方法
JP2001322936A (ja) 眼科用組成物
JP4849288B2 (ja) 点眼剤及び涙液膜の安定化剤
JP2001261578A (ja) 眼科用組成物
JP2005008596A (ja) 眼科用組成物
AU2017294686B2 (en) Use of xibornol as active agent in the treatment of viral infections